About the Company - Dr Reddys Laboratories Ltd
Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 14405.20 Cr. and Equity Capital is Rs. 83.20 Cr. for the Year ended 31/03/2022.
Management |
---|
Name | Position Held |
---|
Mr. K Satish Reddy | Chairman |
Mr. G V Prasad | Co-Chairman & Manag. Director |
Ms. Kalpana Morparia | Independent Director |
Mr. Leo Puri | Independent Director |
Dr. Claudio Albrecht | Independent Director |
Ms. Shikha Sharma | Independent Director |
Ms. Penny Wan | Independent Director |
Mr. Sridar Iyengar | Independent Director |
Mr. Arun Madhavan Kumar | Independent Director |
Dr. K P Krishnan | Independent Director |
Dr. Reddy's Laboratories Ltd. Share Price Update |
---|
Share Price | Value |
---|
Today | ₹5,719.85 |
Previous Day | ₹5,671.25 |
Basic Stock Data of Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Ltd Quarterly Results
Month | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|
Sales | 4,911 | 4,942 | 4,768 | 4,945 | 5,787 | 5,338 | 5,475 | 5,233 | 6,332 | 6,790 | 6,315 | 6,758 | 6,903 |
Expenses | 3,755 | 4,403 | 3,715 | 4,211 | 4,427 | 4,123 | 5,024 | 4,292 | 4,433 | 4,851 | 4,781 | 4,696 | 4,894 |
Operating Profit | 1,156 | 539 | 1,053 | 734 | 1,360 | 1,216 | 451 | 941 | 1,899 | 1,939 | 1,534 | 2,062 | 2,008 |
OPM % | 24% | 11% | 22% | 15% | 24% | 23% | 8% | 18% | 30% | 29% | 24% | 31% | 29% |
Other Income | 58 | 86 | 100 | 124 | 230 | 74 | 132 | 863 | 55 | 65 | 146 | 178 | 319 |
Interest | 25 | 19 | 30 | 19 | 23 | 22 | 32 | 35 | 31 | 42 | 35 | 37 | 35 |
Depreciation | 316 | 311 | 309 | 284 | 294 | 294 | 293 | 302 | 309 | 324 | 316 | 353 | 376 |
Profit before tax | 873 | 295 | 815 | 556 | 1,272 | 974 | 259 | 1,468 | 1,614 | 1,638 | 1,329 | 1,850 | 1,917 |
Tax % | 12% | 91% | 32% | 32% | 22% | 27% | 63% | 19% | 31% | 24% | 28% | 24% | 23% |
Net Profit | 772 | 28 | 557 | 380 | 996 | 709 | 97 | 1,189 | 1,114 | 1,244 | 960 | 1,405 | 1,482 |
EPS in Rs | 46.42 | 1.68 | 33.51 | 22.87 | 59.84 | 42.62 | 5.83 | 71.44 | 66.93 | 74.70 | 57.65 | 84.36 | 88.87 |
Dr Reddys Laboratories Ltd Quarterly Chart
Dr Reddys Laboratories Ltd Profit & Loss
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|
Sales | 9,814 | 11,833 | 13,415 | 15,023 | 15,568 | 14,196 | 14,281 | 15,448 | 17,517 | 19,048 | 21,545 | 24,670 | 26,766 |
Expenses | 7,371 | 9,164 | 10,164 | 11,515 | 11,983 | 11,724 | 11,930 | 12,270 | 15,040 | 15,173 | 17,778 | 18,200 | 19,223 |
Operating Profit | 2,444 | 2,669 | 3,251 | 3,508 | 3,585 | 2,472 | 2,351 | 3,178 | 2,477 | 3,874 | 3,768 | 6,470 | 7,543 |
OPM % | 25% | 23% | 24% | 23% | 23% | 17% | 16% | 21% | 14% | 20% | 17% | 26% | 28% |
Other Income | -7 | 146 | 170 | 260 | 295 | 172 | 155 | 381 | 670 | 335 | 555 | 971 | 708 |
Interest | 114 | 100 | 127 | 108 | 83 | 63 | 79 | 89 | 98 | 97 | 96 | 143 | 150 |
Depreciation | 518 | 550 | 648 | 760 | 939 | 1,027 | 1,077 | 1,135 | 1,163 | 1,229 | 1,165 | 1,250 | 1,368 |
Profit before tax | 1,804 | 2,165 | 2,646 | 2,900 | 2,859 | 1,554 | 1,350 | 2,336 | 1,886 | 2,884 | 3,061 | 6,048 | 6,734 |
Tax % | 28% | 29% | 26% | 19% | 26% | 19% | 32% | 17% | -7% | 32% | 29% | 25% | |
Net Profit | 1,301 | 1,527 | 1,963 | 2,336 | 2,131 | 1,292 | 947 | 1,950 | 2,026 | 1,952 | 2,182 | 4,507 | 5,091 |
EPS in Rs | 76.72 | 89.90 | 115.41 | 137.13 | 124.88 | 77.96 | 57.07 | 117.42 | 121.92 | 117.35 | 131.14 | 270.66 | 305.58 |
Dividend Payout % | 18% | 17% | 16% | 15% | 16% | 26% | 35% | 17% | 21% | 21% | 23% | 15% | |
Dr Reddys Laboratories Ltd Profit & Loss Yearly Chart
Dr Reddys Laboratories Ltd Growth
|
Compounded Sales Growth |
---|
10 Years:: | 8% |
5 Years:: | 12% |
3 Years:: | 12% |
TTM:: | 20% |
Dr Reddys Laboratories Ltd Growth
|
Compounded Profit Growth |
---|
10 Years:: | 12% |
5 Years:: | 39% |
3 Years:: | 31% |
TTM:: | 64% |
Dr Reddys Laboratories Ltd Growth
|
Stock Price CAGR |
---|
10 Years:: | 9% |
5 Years:: | 16% |
3 Years:: | 6% |
1 Year:: | 28% |
Dr Reddys Laboratories Ltd Growth
|
Return on Equity |
---|
10 Years:: | 15% |
5 Years:: | 15% |
3 Years:: | 15% |
Last Year:: | 22% |
Dr Reddys Laboratories Ltd Balance Sheet
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 |
---|
Equity Capital | 85 | 85 | 85 | 85 | 85 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 |
Reserves | 4,904 | 6,284 | 7,780 | 9,768 | 12,484 | 12,179 | 12,489 | 13,941 | 15,516 | 17,558 | 19,129 | 23,203 | 25,413 |
Borrowings | 3,234 | 3,682 | 4,477 | 4,314 | 3,352 | 4,918 | 5,071 | 3,838 | 2,210 | 3,031 | 3,384 | 1,347 | 1,323 |
Other Liabilities | 3,082 | 3,329 | 3,563 | 4,290 | 4,408 | 4,474 | 4,706 | 4,557 | 5,414 | 5,915 | 7,149 | 7,576 | 7,990 |
Total Liabilities | 11,305 | 13,380 | 15,906 | 18,457 | 20,330 | 21,654 | 22,349 | 22,418 | 23,223 | 26,588 | 29,746 | 32,209 | 34,809 |
Fixed Assets | 3,412 | 4,051 | 4,641 | 5,377 | 6,563 | 6,931 | 6,968 | 7,191 | 6,850 | 8,206 | 8,122 | 9,219 | 10,090 |
CWIP | 708 | 565 | 639 | 529 | 772 | 3,324 | 3,470 | 2,934 | 1,535 | 1,565 | 1,293 | 1,030 | 1,151 |
Investments | 208 | 197 | 1,067 | 2,248 | 3,833 | 2,110 | 2,298 | 2,587 | 2,678 | 2,212 | 2,616 | 4,986 | 4,457 |
Other Assets | 6,977 | 8,567 | 9,559 | 10,303 | 9,162 | 9,290 | 9,612 | 9,707 | 12,160 | 14,605 | 17,715 | 16,974 | 19,111 |
Total Assets | 11,305 | 13,380 | 15,906 | 18,457 | 20,330 | 21,654 | 22,349 | 22,418 | 23,223 | 26,588 | 29,746 | 32,209 | 34,809 |
Dr Reddys Laboratories Ltd Reserves and Borrowings Chart
Dr Reddys Laboratories Ltd Cash Flow
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|
Cash from Operating Activity | 1,613 | 1,378 | 1,970 | 2,524 | 3,263 | 2,144 | 1,803 | 2,870 | 2,984 | 3,570 | 2,811 | 5,888 |
Cash from Investing Activity | -971 | -1,437 | -1,604 | -2,370 | -1,610 | -1,890 | -1,483 | -769 | -495 | -2,255 | -2,565 | -4,109 |
Cash from Financing Activity | 389 | -157 | -24 | -433 | -1,700 | -369 | -444 | -2,133 | -2,516 | -30 | -242 | -2,686 |
Net Cash Flow | 1,031 | -216 | 342 | -280 | -47 | -114 | -124 | -31 | -27 | 1,286 | 3 | -907 |
|
Dr Reddys Laboratories Ltd Financial Efficiency Indicators
Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|
Debtor Days | 94 | 98 | 90 | 100 | 97 | 98 | 104 | 94 | 105 | 95 | 113 | 107 |
Inventory Days | 282 | 229 | 271 | 248 | 248 | 282 | 263 | 273 | 230 | 273 | 250 | 232 |
Days Payable | 110 | 102 | 100 | 84 | 88 | 104 | 121 | 111 | 100 | 109 | 111 | 108 |
Cash Conversion Cycle | 267 | 225 | 261 | 264 | 257 | 275 | 246 | 256 | 235 | 259 | 252 | 231 |
Working Capital Days | 81 | 79 | 88 | 79 | 87 | 98 | 104 | 93 | 93 | 103 | 108 | 102 |
ROCE % | 28% | 25% | 25% | 22% | 19% | 9% | 8% | 13% | 11% | 16% | 14% | 27% |
Dr Reddys Laboratories Ltd Financial Efficiency Indicators Chart
No valid data available for the Shareholding
Dr Reddys Laboratories Ltd Shareholding Pattern Chart
No. of Dr Reddys Laboratories Ltd Shareholders
Dr Reddys Laboratories Ltd Mutual Fund Holdings
Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) |
---|
SBI Nifty 50 ETF | 2259610 | 0.78 | 1212.86 |
HDFC Flexi Cap Fund - Regular Plan | 1200000 | 1.63 | 644.11 |
Parag Parikh Flexi Cap Fund | 811835 | 0.99 | 435.76 |
HDFC ELSS Tax Saver Fund | 600000 | 2.86 | 322.05 |
Nippon India Pharma Fund | 550030 | 5.33 | 295.23 |
SBI Arbitrage Opportunities Fund | 327750 | 0.79 | 175.92 |
HDFC Arbitrage Fund - Regular Plan | 304250 | 2.16 | 163.31 |
HDFC Arbitrage Fund - Wholesale Plan | 304250 | 2.16 | 163.31 |
Mirae Asset Healthcare Fund | 282346 | 8.5 | 151.55 |
Tata Equity P/E Fund - Regular Plan | 270000 | 2.43 | 144.92 |
Dr Reddys Laboratories Ltd ROCE Trend
Dr Reddys Laboratories Ltd EPS Trend
Dr Reddys Laboratories Ltd Key Financial Ratios
Month | Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 |
---|
FaceValue | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Basic EPS (Rs.) | 271.47 | 131.57 | 117.67 | 122.22 | 117.53 |
Diluted EPS (Rs.) | 270.90 | 131.21 | 117.34 | 121.99 | 117.33 |
Cash EPS (Rs.) | 343.37 | 196.96 | 188.25 | 188.51 | 183.19 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 1397.72 | 1154.59 | 1060.20 | 938.56 | 844.79 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 1397.72 | 1154.59 | 1060.20 | 938.56 | 844.79 |
Revenue From Operations / Share (Rs.) | 1480.77 | 1294.78 | 1144.68 | 1053.97 | 930.61 |
PBDIT / Share (Rs.) | 444.45 | 255.53 | 250.08 | 185.98 | 211.79 |
PBIT / Share (Rs.) | 369.41 | 185.51 | 176.23 | 116.00 | 143.43 |
PBT / Share (Rs.) | 360.83 | 179.75 | 170.40 | 110.08 | 138.07 |
Net Profit / Share (Rs.) | 268.32 | 126.94 | 114.40 | 118.53 | 114.83 |
NP After MI And SOA / Share (Rs.) | 270.55 | 131.16 | 117.28 | 121.90 | 117.47 |
PBDIT Margin (%) | 30.01 | 19.73 | 21.84 | 17.64 | 22.75 |
PBIT Margin (%) | 24.94 | 14.32 | 15.39 | 11.00 | 15.41 |
PBT Margin (%) | 24.36 | 13.88 | 14.88 | 10.44 | 14.83 |
Net Profit Margin (%) | 18.12 | 9.80 | 9.99 | 11.24 | 12.33 |
NP After MI And SOA Margin (%) | 18.27 | 10.12 | 10.24 | 11.56 | 12.62 |
Return on Networth / Equity (%) | 19.35 | 11.35 | 11.06 | 12.98 | 13.90 |
Return on Capital Employeed (%) | 25.95 | 15.44 | 15.84 | 12.04 | 14.37 |
Return On Assets (%) | 13.96 | 7.33 | 7.33 | 8.72 | 8.67 |
Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.02 | 0.01 | 0.15 |
Total Debt / Equity (X) | 0.04 | 0.16 | 0.15 | 0.11 | 0.24 |
Asset Turnover Ratio (%) | 0.61 | 0.56 | 0.59 | 0.56 | 0.54 |
Current Ratio (X) | 2.38 | 1.82 | 1.80 | 1.75 | 1.88 |
Quick Ratio (X) | 1.81 | 1.30 | 1.24 | 1.26 | 1.31 |
Inventory Turnover Ratio (X) | 0.77 | 0.85 | 1.03 | 0.92 | 0.85 |
Dividend Payout Ratio (NP) (%) | 11.04 | 18.99 | 21.24 | 19.32 | 17.02 |
Dividend Payout Ratio (CP) (%) | 8.64 | 12.38 | 13.03 | 12.27 | 10.76 |
Earning Retention Ratio (%) | 88.96 | 81.01 | 78.76 | 80.68 | 82.98 |
Cash Earning Retention Ratio (%) | 91.36 | 87.62 | 86.97 | 87.73 | 89.24 |
Interest Coverage Ratio (%) | 51.85 | 44.39 | 42.90 | 31.44 | 39.55 |
Interest Coverage Ratio (Post Tax) (%) | 32.30 | 23.05 | 20.62 | 21.04 | 22.44 |
Enterprise Value (Cr.) | 76382.99 | 72310.86 | 75755.28 | 53384.50 | 49240.59 |
EV / Net Operating Revenue (X) | 3.10 | 3.36 | 3.98 | 3.05 | 3.19 |
EV / EBITDA (X) | 10.32 | 17.01 | 18.20 | 17.27 | 14.01 |
MarketCap / Net Operating Revenue (X) | 3.12 | 3.33 | 3.94 | 2.96 | 2.98 |
Retention Ratios (%) | 88.95 | 81.00 | 78.75 | 80.67 | 82.97 |
Price / BV (X) | 3.31 | 3.73 | 4.26 | 3.32 | 3.28 |
Price / Net Operating Revenue (X) | 3.12 | 3.33 | 3.94 | 2.96 | 2.98 |
EarningsYield | 0.05 | 0.03 | 0.02 | 0.03 | 0.04 |
Dr Reddys Laboratories Ltd Profitability Ratios (%)
Dr Reddys Laboratories Ltd Liquidity Ratios
Dr Reddys Laboratories Ltd Liquidity Ratios (%)
Dr Reddys Laboratories Ltd Interest Coverage Ratios (%)
Dr Reddys Laboratories Ltd Valuation Ratios
Data is incomplete for fair value calculation.
Strength and Weakness of Dr Reddys Laboratories Ltd Stock
Strength | Weakness |
---|
The company has higher reserves compared to borrowings, indicating strong financial stability. The company has shown consistent growth in sales and profit over the years. | The stock has a low average ROCE, which may not be favorable. The stock has a high average Working Capital Days, which may not be favorable. The stock has a high average Cash Conversion Cycle, which may not be favorable. |